Mechanical and degradation properties of poly(methyl methacrylate) cement/borate bioactive glass composites
Source abstract
Abstract
Abstract Bone cement is used extensively in orthopedics to anchor prostheses to bone and fill voids. Incorporating bioactive glass into poly(methyl methacrylate) (PMMA)‐based bone cement could potentially improve its effectiveness for these tasks. This study characterizes the mechanical and degradation properties of composites containing PMMA‐based bone cement and particles of borate bioactive glass designated as 13‐93B3. Glass particles of size 5, 33, and 100 μm were mixed with PMMA bone cement to create composites containing 20, 30, and 40 wt % glass. Composites and a bone cement control were soaked in phosphate‐buffered saline. Compressive strength, Young's modulus, weight loss, water uptake, solution pH, and ionic concentrations were measured over 21 days. The compressive strengths of composites decreased over 21 days. Average Young's moduli of the composites remained below 3 GPa. Weight loss and water uptake of specimens did not exceed 2 and 6%, respectively. Boron concentrations and pH of all solutions increased over time, with higher glass weight fractions leading to higher pH values. Results demonstrated that the composite can sustain glass degradation and ionic release without compromising short‐term mechanical strength.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Dental materials and restorations
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Orthopedic Surgery University of Kansas Medical Center Kansas City Kansas
Department of Materials Science and Engineering Missouri University of Science and Technology Rolla Missouri
Funding
Marc A. and Elinor J. Asher Orthopedic Research Endowment
References (33)
Show source-provided references
1. 10.1016/j.saa.2012.02.05110.1016/j.saa.2012.02.051 ↗
2. ASTM Standard F451‐16 · 2016 · 1
3. 10.3390/jfb901002510.3390/jfb9010025 ↗
4. 10.1016/j.actbio.2013.04.04310.1016/j.actbio.2013.04.043 ↗
5. 10.1081/E-EBPP-12005059810.1081/E-EBPP-120050598 ↗
6. Characterization of the conversion of bone cement and borate bioactive glass composites
7. 10.1007/s10856-013-4996-010.1007/s10856-013-4996-0 ↗
8. 10.1098/rsif.2016.105710.1098/rsif.2016.1057 ↗
9. 10.1016/j.jnoncrysol.2015.06.00110.1016/j.jnoncrysol.2015.06.001 ↗
10. 10.1002/(SICI)1097-4636(1999)48:5<719::AID-JBM18>3.0.CO;2-H10.1002/(SICI)1097-4636(1999)48:5<719::AID-JBM18>3.0.CO;2-H ↗
11. 10.3390/jfb901002410.3390/jfb9010024 ↗
12. 10.1302/0301-620X.64B4.709642910.1302/0301-620X.64B4.7096429 ↗
13. 10.1002/jbm.a.3282310.1002/jbm.a.32823 ↗
14. 10.1002/jbm.a.3282410.1002/jbm.a.32824 ↗
15. 10.1016/j.compositesb.2008.01.00210.1016/j.compositesb.2008.01.002 ↗
16. 10.7150/jbji.2734810.7150/jbji.27348 ↗
17. George J. L · 2015
18. 10.1002/app.3529510.1002/app.35295 ↗
19. 10.5772/5325210.5772/53252 ↗
20. The relationship between stress shielding and bone resorption around total hip stems and the effects of flexible materials10.1097/00003086-199201000-00014 ↗
21. ISO 5833:2002 · 2002
22. 10.1002/jbm.a.3469010.1002/jbm.a.34690 ↗
23. 10.1007/s10856-009-3691-710.1007/s10856-009-3691-7 ↗
24. 10.1007/s10856-012-4831-z10.1007/s10856-012-4831-z ↗
25. 10.1177/088532821245709710.1177/0885328212457097 ↗
26. 10.3233/BME-2012-067910.3233/BME-2012-0679 ↗
27. 10.1016/j.msec.2014.04.05510.1016/j.msec.2014.04.055 ↗
28. 10.1002/1097-4636(20010905)56:3<452::AID-JBM1115>3.0.CO;2-110.1002/1097-4636(20010905)56:3<452::AID-JBM1115>3.0.CO;2-1 ↗
29. 10.1002/1097-4636(20010315)54:4<491::AID-JBM40>3.0.CO;2-O10.1002/1097-4636(20010315)54:4<491::AID-JBM40>3.0.CO;2-O ↗
30. 10.1002/jbm.123610.1002/jbm.1236 ↗
31. U.S. Department of Health and Human Services, Food and Drug Administration. · 2016
32. 10.1080/00016470131726897810.1080/000164701317268978 ↗
33. 10.1302/0301-620X.89B7.1914810.1302/0301-620X.89B7.19148 ↗